Indeed, several reports have demonstrated pharmacologic inhibition or genetic silencing of TNKS1/2 to have strong tumor inhibiting effects in cellular and animal models of cancers (Casás-Selves et al., 2012; de la Roche et al., 2014). This evidence concerns the gene TNKS and neoplasm.